Abstract
Lung malignancy is a major cause of human mortality. As such, safe pharmacological agents that can detect lung cancer are urgently required. Magnolol has been reported to have anticancer property. However, it is still unclear whether magnolol induces apoptosis of lung carcinoma cells. In this study, magnolol inhibited cell growth, increased lactate dehydrogenase release, and modulated cell cycle in human lung carcinoma A549 cells. Magnolol induced the activation of caspase-3 and cleavage of Poly-(ADP)-ribose polymerase, and decreased the expression level of nuclear factor-κB/Rel A in the nucleus. In addition, magnolol inhibited basic fibroblast growth factor-induced proliferation and capillary tube formation of human umbilical vein endothelial cells. These data indicate that magnolol is a potential candidate for treating of human lung carcinoma.
Similar content being viewed by others
References
Alvero, A. B., Montagna, M. K., Chen, R., Kim, K. H., Kim, K., Visintin, I., Fu, H.-H., Brown, D., and Mor, G., NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway. Cancer, 115, 3204–3216 (2009).
Ashkenazi, A. and Dixit, V. M., Death receptors: signaling and modulation. Science, 281, 1305–1308 (1998).
Bussolino, F., Mantovani, A., and Persico, G., Molecular mechanisms of blood vessel formation. Trends Biochem. Sci., 22, 251–256 (1997).
Chen, J. S., Chen, Y. L., Greenberg, A. S., Chen, Y. J., and Wang, S. M., Magnolol stimulates lipolysis in lipid-laden RAW 264.7 macrophages. J. Cell. Biochem., 94, 1028–1037 (2005a).
Chen, Y. C., Chang, M. F., Chen, Y., and Wang, S. M., Signaling pathways of magnolol-induced adrenal steroidogenesis. FEBS Lett., 579, 4337–4343 (2005b).
Chou, C. C., Wu, Y. C., Wang, Y. F., Chou, M. J., Kuo, S. J., and Chen, D. R., Capsaicin-induced apoptosis in human breast cancer MCF-7 cells through caspase-independent pathway. Oncol. Rep., 21, 665–671 (2009).
Cohen, G. M., Caspases: the executioners of apoptosis. Biochem. J., 326, 1–16 (1997).
Dove, A., Making a living out of the art of dying. Nat. Biotechnol., 19, 615–619 (2001).
Fan, T. P., Jaggar, R., and Bicknell, R., Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci., 16, 57–66 (1995).
Gordon, M. S., Mendelson, D. S., and Kato, G., Tumor angiogenesis and novel antiangiogenic strategies. Int. J. Cancer, 126, 1777–1787 (2010).
Hengartner, M. O., The biochemistry of apoptosis. Nature, 407, 770–776 (2000).
Herr, I. and Debatin, K. M., Cellular stress response and apoptosis in cancer therapy. Blood, 98, 2603–2614 (2001).
Hirano, T., Gotoh, M., and Oka, K., Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci., 55, 1061–1069 (1994).
Hu, C. B., Chen, C. P., Yeh, T. K., Song, J. S., Chang, C. Y., Chuu, J. J., Tung, F. F., Ho, P. Y., Chen, T. W., Lin, C. H., Wang, M. H., Chang, K. Y., Huang, C. L., Lin, H. L., Li, W. T., Hwang, D. R., Chern, J. H., Hwang, L. L., Chang, J. Y., Chao, Y. S., and Chen, C. T., BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities. Cancer Sci., 102, 182–191 (2011).
Huang, S. H., Shen, W. J., Yeo, H. L., and Wang, S. M., Signaling pathway of magnolol-stimulated lipolysis in sterol ester-loaded 3T3-L1 preadipocytes. J. Cell. Biochem., 91, 1021–1029 (2004).
Huang, S. H., Chen, Y., Tung, P. Y., Wu, J. C., Chen, K. H., Wu, J. M., and Wang, S. M., Mechanisms for the magnolol-induced cell death of CGTH W-2 thyroid carcinoma cells. J. Cell. Biochem., 101, 1011–1022 (2007).
Ikeda, K. and Nagase, H., Magnolol has the ability to induce apoptosis in tumor cells. Biol. Pharm. Bull., 25, 1546–1549 (2002).
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J., Cancer statistics, 2009. CA Cancer J. Clin., 59, 225–249 (2009).
Kao, Y. H., Jawan, B., Sun, C. K., Goto, S., Lin, Y. C., Hung, C. T., Pan, M. C., Hsu, L. W., Cheng, Y. F., Lai, C. Y., Wang, C. S., Tsai, C. C., Chang, H. R., and Chen, C. L., High concentration of magnolol induces hepatotoxicity under serum-reduced conditions. Phytomedicine, 17, 469–474 (2010).
Kelloff, G. J., Perspectives on cancer chemoprevention research and drug development. Adv. Cancer Res., 78, 199–334 (2000).
Kim, B.-M., Won, J., Maeng, K. A., Han, Y.-S., Yun, Y.-S., and Hong, S.-H., Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3. Int. J. Oncol., 34, 1467–1473 (2009).
Konoshima, T., Kozuka, M., Tokuda, H., Nishino, H., Iwashima, A., Haruna, M., Ito, K., and Tanabe, M., Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J. Nat. Prod., 54, 816–822 (1991).
Koshimune, R., Aoe, M., Toyooka, S., Hara, F., Ouchida, M., Tokumo, M., Sano, Y., Date, H., and Shimizu, N., Antitumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines. BMC Cancer, 7, 8 (2007).
Li, H. B., Yi, X., Gao, J. M., Ying, X. X., Guan, H. Q., and Li, J. C., Magnolol-induced H460 cells death via autophagy but not apoptosis. Arch. Pharm. Res., 30, 1566–1574 (2007a).
Li, H. B., Gao, J. M., Ying, X. X., Wang, S. P., and Li, J. C., Protective effect of magnolol on TBHP-induced injury in H460 cells partially via a p53 dependent mechanism. Arch. Pharm. Res., 30, 850–857 (2007b).
Lin, S. Y., Chang, Y. T., Liu, J. D., Yu, C. H., Ho, Y. S., Lee, Y. H., and Lee, W. S., Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol. Carcinog., 32, 73–83 (2001).
Lin, S. Y., Liu, J. D., Chang, H. C., Yeh, S. D., Lin, C. H., and Lee, W. S., Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J. Cell. Biochem., 84, 532–544 (2002).
Nagase, H., Ikeda, K., and Sakai, Y., Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro. Planta Med., 67, 705–708 (2001).
Nagata, S., Apoptosis by death factor. Cell, 88, 355–365 (1997).
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J. Jr., and Sledge, G. W. Jr., Constitutive activation of NFkappaB during progression of breast cancer to hormoneindependent growth. Mol. Cell. Biol., 17, 3629–3639 (1997).
Putt, K. S., Chen, G. W., Pearson, J. M., Sandhorst, J. S., Hoagland, M. S., Kwon, J. T., Hwang, S.-K., Jin, H., Churchwell, M. I., Cho, M.-H., Doerge, D. R., Helferich, W. G., and Hergenrother, P. J., Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat. Chem. Biol., 2, 543–550 (2006).
Reynolds, A. R., Potential relevance of bell-shaped and ushaped dose-responses for the therapeutic targeting of angiogenesis in cancer. Dose Response, 8, 253–284 (2010).
Sher, T., Dy, G. K., and Adjei, A. A., Small cell lung cancer. Mayo Clin. Proc., 83, 355–367 (2008).
Thompson, C. B., Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456–1462 (1995).
Wang, S. M., Lee, L. J., Huang, Y. T., Chen, J. J., and Chen, Y. L., Magnolol stimulates steroidogenesis in rat adrenal cells. Br. J. Pharmacol., 131, 1172–1178 (2000).
Woodle, E. S. and Kulkarni, S., Programmed cell death. Transplantation, 66, 681–691 (1998).
Yang, S. E., Hsieh, M. T., Tsai, T. H., and Hsu, S. L., Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells. Br. J. Pharmacol., 138, 193–201 (2003).
Zhong, W. B., Wang, C. Y., Ho, K. J., Lu, F. J., Chang, T. C., and Lee, W. S., Magnolol induces apoptosis in human leukemia cells via cytochrome c release and caspase activation. Anticancer Drugs, 14, 211–217 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Seo, JU., Kim, MH., Kim, HM. et al. Anticancer potential of magnolol for lung cancer treatment. Arch. Pharm. Res. 34, 625–633 (2011). https://doi.org/10.1007/s12272-011-0413-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0413-8